This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis. Objectives: To estimate the ...
“The ‘cost-based approach’ minimizes the risk of mixing the value of a technology with the value of a standard as such. Instead, it uses market forces to calculate a rate based on continued investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results